MedTrace Logo

Is Mg do Improve the Glycemic Control in Patients Drink a Desalinate Water

NCT04632277 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2021-09-29

No results posted yet for this study

Summary

Background and aim:

Diabetes mellitus as a chronic disease is on rise on parallel with diseases. Magnesium (Mg) supplementation may help control glycemic response among type 2 diabetes (T2D) patients. We aim to present an overview of the possible influence of drinking water in general and mineral water in particular in improving glycemic parameters in persons with type 2 diabetes.

Method:

A randomized double blind controlled clinical trial will be conducted at the Endocrine clinic (KFHU) on 900 of patients with T2DM. All subjects participated in this study will be randomly allotted into three groups (each group N=300) to which the three waters were supplied in similar bottles marked A "tap water", B "bottle water" and C "control without any intervention".

Blood samples will be taken before and after the intervention to determine the serum concentration of magnesium, Calcium, Vit D, creatinine, FBS, serum Ca, HbA1c, fasting C-peptide levels, fasting insulin levels and insulin sensitivity. Magnesium and calcium levels in urine will be expressed as the creatinine ratio

Conditions

Interventions

OTHER

Water

Participants will receive a tab water

DIETARY_SUPPLEMENT

Water with low Mg

Participants will receive Low Mg bottle water (50mg/l)

DIETARY_SUPPLEMENT

Water with high Mg

Participants will receive High Mg bottle water (100mg/l)

Sponsors & Collaborators

  • The Saline Water Conversion Corporation Research Institute at Al-Jubail, KSA.

    collaborator UNKNOWN

  • Imam Abdulrahman Bin Faisal University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-25
Primary Completion
2021-05-01
Completion
2021-08-01

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04632277 on ClinicalTrials.gov